CCND1 Gene Colorectal Cancer Hereditary Susceptibility to Genetic Test sale cost 4400 AED
XRCC3 Gene Breast Cancer Susceptibility to Genetic Test sale cost 4400 AED XRCC3 Gene Breast Cancer Susceptibility to Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
NCF1 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B-Positive Type 1 Genetic Test sale cost 4400 AED NCF1 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B-Positive Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CCND1 Gene Colorectal Cancer Hereditary Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CCND1 gene plays a significant role in cell cycle regulation, making it a critical factor in understanding the genetic susceptibility to colorectal cancer. The CCND1 Gene Colorectal Cancer Hereditary Susceptibility Genetic Test is a specialized diagnostic tool aimed at identifying mutations or alterations in the CCND1 gene that may increase an individual’s risk of developing colorectal cancer. This test is particularly relevant for individuals with a family history of colorectal cancer, as it can provide valuable insights into their genetic predisposition to the disease.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test employs advanced genomic technologies to analyze the CCND1 gene for specific mutations associated with an increased risk of colorectal cancer. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then meticulously examined for any genetic variations in the CCND1 gene.

The cost of the CCND1 Gene Colorectal Cancer Hereditary Susceptibility Genetic Test is 4400 AED. While the price may seem steep, the test offers invaluable information that can empower individuals and their healthcare providers to take proactive steps in managing their cancer risk. This could include more frequent screenings, lifestyle modifications, or even preventative treatments, all aimed at reducing the likelihood of developing colorectal cancer.

Overall, the CCND1 Gene Colorectal Cancer Hereditary Susceptibility Genetic Test is a vital resource for individuals at risk of hereditary colorectal cancer, offering them the chance to take control of their health through informed decision-making.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CCND1 Gene Colorectal Cancer Hereditary Susceptibility to Genetic Test

At DNA Labs UAE, we offer the CCND1 Gene Colorectal cancer hereditary susceptibility to Genetic Test at a price of 4400.0 AED. This test is used to determine the risk of developing colorectal cancer based on genetic factors.

Test Details

The CCND1 gene codes for a protein called cyclin D1, which plays a role in regulating the cell cycle. Mutations in this gene have been linked to various types of cancer, including colorectal cancer.

Colorectal cancer is the third most common cancer worldwide and can be caused by a combination of genetic and environmental factors. In some cases, there is a hereditary component to the disease, meaning that certain genetic mutations can increase the risk of developing colorectal cancer.

NGS Technology

Our CCND1 Gene Colorectal cancer hereditary susceptibility to Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This advanced genetic testing method allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of an individual’s genetic makeup.

NGS genetic testing can identify mutations or variations in genes such as CCND1 that may increase an individual’s susceptibility to colorectal cancer. This information can be used to develop personalized medical management strategies, including increased surveillance, preventive measures, or targeted therapies.

Pre Test Information

Prior to undergoing the CCND1 Gene Colorectal cancer hereditary susceptibility to Genetic Test, it is important to provide a clinical history of the patient. This includes information about any family members who have been affected by CCND1 Gene Colorectal cancer. A genetic counseling session will also be conducted to draw a pedigree chart of the family members.

Report Delivery and Test Department

After the test is conducted, the report will be delivered within 3 to 4 weeks. The test is conducted by our Genetics department, under the supervision of an Oncologist.

Who Should Undergo Genetic Testing?

It is important to note that NGS genetic testing is not recommended for everyone. It is typically reserved for individuals with a strong family history of colorectal cancer or other risk factors that suggest a potential hereditary component to the disease.

Genetic testing should always be done under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and follow-up care.

Test Name CCND1 Gene Colorectal cancer hereditary susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CCND1 Gene Colorectal cancer, hereditary, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CCND1 Gene Colorectal cancer, hereditary, susceptibility to NGS Genetic DNA Test gene CCND1
Test Details

The CCND1 gene is a gene that codes for a protein called cyclin D1, which is involved in regulating the cell cycle. Mutations in this gene have been associated with various types of cancer, including colorectal cancer.

Colorectal cancer is a type of cancer that affects the colon or rectum. It is the third most common cancer worldwide and can be caused by a combination of genetic and environmental factors. In some cases, there is a hereditary component to colorectal cancer, meaning that certain genetic mutations can increase a person’s susceptibility to developing the disease.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous sequencing of multiple genes. It can provide a comprehensive analysis of an individual’s genetic makeup and identify mutations or variations that may be associated with an increased risk of developing certain diseases, including colorectal cancer.

In the context of colorectal cancer, NGS genetic testing can be used to identify mutations in genes such as CCND1 that may increase an individual’s susceptibility to the disease. This information can be used to inform personalized medical management strategies, including increased surveillance, preventive measures, or targeted therapies.

It is important to note that NGS genetic testing is not typically recommended for everyone. It is usually reserved for individuals with a strong family history of colorectal cancer or other risk factors that suggest a potential hereditary component to the disease. Genetic testing should be done under the guidance of a healthcare professional who can help interpret the results and provide appropriate counseling and follow-up care.

SKU: TEST-4475 Category:

Related products